The global skin cancer diagnosis and therapeutics market are anticipated to grow at a considerable CAGR of around 7.5% during the forecast period (2021-2027). One of the major drivers of the market is the increasing demand for skin cancer therapies such as radiation therapy, chemotherapy, immunotherapy, and other drug therapy. There has been an increased adoption rate of these therapeutics among the patients, which is likely to increase the market growth. According to WHO, the rate of both non-melanoma and melanoma skin cancers has been increasing day by day. Around 3 million non-melanoma skin cancers, and 132,000 melanoma skin cancers occur across the globe. In addition to that, several government initiatives have proven to be favorable for the skin cancer diagnosis and therapeutics market. Besides, there is a lack of awareness among the patients in emerging countries about the availability of this form of treatment is a restraint of the market.
To Request a Sample of our Report on Skin Cancer Diagnosis and Therapeutics Market: https://www.omrglobal.com/request-sample/skin-cancer-diagnosis-and-therapeutics-market
In addition, to create opportunities the key players operating in the market have been inventing new drugs with FDA approval of several new immunotherapies. For instance, In June 2020, Merck & Co., Inc. received approval for pembrolizumab for cutaneous squamous cell carcinoma from the US Food and Drug Administration (FDA). The drug is used for the treatment of a patient having metastatic cutaneous squamous cell carcinoma (CSCC) that is not treatable by surgery or radiation.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Type
· By Therapy
· By Diagnosis
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape – Pfizer Inc., Merck & co. Inc., Bristol Myers Squibb co., Novartis International AG, Sanofi S.A., Bausch Health Companies Inc., and others
Key questions addressed by the report
· What is the market growth rate?
· Which segment and region dominate the market in the base year?
· Which segment and region will project the fastest growth in the market?
· How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
· Who is the leader in the market?
· How are players addressing challenges to sustain growth?
· Where is the investment opportunity?
(Get 15% Discount on Buying this Report)
A full Report of Skin Cancer Diagnosis and Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/skin-cancer-diagnosis-and-therapeutics-market
Global Skin Cancer Diagnosis and Therapeutics Market
By Type
· Melanoma
· Non-Melanoma
· By Therapy
· Surgery treatment
· Radiotherapy
· Chemotherapy
· Targeted therapy
· Immunotherapy
· Others
By Diagnosis
· Dermatoscopy
· Biopsy
· Blood test
· X-rays
· Others
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
